Feasibility of reduced-dose posttransplant cyclophosphamide and cotransplantation of peripheral blood stem cells and umbilical cord-derived mesenchymal stem cells for SAA

Abstract Posttransplant cyclophosphamide (PTCy) as graft-versus-host disease (GVHD) prophylaxis is an effective strategie for patients receiving matched sibling donor hematopoietic stem cell transplantation (MSD-HSCT) and haploidentical HSCT (haplo-HSCT). We evaluated the effectiveness and safety of...

Disgrifiad llawn

Manylion Llyfryddiaeth

Prif Awduron:	Yingling Zu, Jian Zhou, Yuewen Fu, Baijun Fang, Xinjian Liu, Yanli Zhang, Fengkuan Yu, Wenli Zuo, Hu Zhou, Ruirui Gui, Zhen Li, Yanyan Liu, Huifang Zhao, Chengjuan Zhang, Yongping Song
Fformat:	Artigo
Iaith:	Inglês
Cyhoeddwyd:	Nature Portfolio 2021-01-01
Cyfres:	Scientific Reports
Mynediad Ar-lein:	https://doi.org/10.1038/s41598-020-80531-7
Tagiau:	Ychwanegu Tag Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!